{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T16:48:55Z","timestamp":1775580535808,"version":"3.50.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R24AA019661"],"award-info":[{"award-number":["R24AA019661"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["K23AA024503"],"award-info":[{"award-number":["K23AA024503"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R01AA029855"],"award-info":[{"award-number":["R01AA029855"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["R01DA051464"],"award-info":[{"award-number":["R01DA051464"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"crossref","award":["R24AA019661"],"award-info":[{"award-number":["R24AA019661"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"crossref","award":["K23AA024503"],"award-info":[{"award-number":["K23AA024503"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"crossref","award":["R01AA029855"],"award-info":[{"award-number":["R01AA029855"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["R01DA051464"],"award-info":[{"award-number":["R01DA051464"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.atsjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>In patients with pneumonia requiring intensive care unit (ICU) admission, alcohol misuse is associated with increased mortality, but the relationship between other commonly misused substances and mortality is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We sought to establish whether alcohol misuse, cannabis misuse, opioid misuse, stimulant misuse, or misuse of more than one of these substances was associated with differences in mortality among ICU patients with pneumonia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective cohort study of hospitals participating in the Premier Healthcare Database between 2010 and 2017. Patients were included if they had a primary or secondary diagnosis of pneumonia and received antibiotics or antivirals within 1 day of admission. Substance misuse related to alcohol, cannabis, stimulants, and opioids, or more than one substance, were identified from the International Classification of Diseases (Ninth and Tenth Editions). The associations between substance misuse and in-hospital mortality were the primary outcomes of interest. Secondary outcomes included the measured associations between substance misuse disorders and mechanical ventilation, as well as vasopressor and continuous paralytic administration. Analyses were conducted with multivariable mixed-effects logistic regression modeling adjusting for age, comorbidities, and hospital characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 167,095 ICU patients met inclusion criteria for pneumonia. Misuse of alcohol was present in 5.0%, cannabis misuse in 0.6%, opioid misuse in 1.5%, stimulant misuse in 0.6%, and misuse of more than one substance in 1.2%. No evidence of substance misuse was found in 91.1% of patients. In unadjusted analyses, alcohol misuse was associated with increased in-hospital mortality (odds ratio [OR], 1.12; 95% confidence interval [CI], 1.06\u20131.19), whereas opioid misuse was associated with decreased in-hospital mortality (OR, 0.46; 95% CI, 0.39\u20130.53) compared with no substance misuse. These findings persisted in adjusted analyses. Although cannabis, stimulant, and more than one substance misuse (a majority of which were alcohol in combination with another substance) were associated with lower odds for in-hospital mortality in unadjusted analyses, these relationships were not consistently present after adjustment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In this study of ICU patients hospitalized with severe pneumonia, substance misuse subtypes were associated with different effects on mortality. Although administrative data can provide epidemiologic insight regarding substance misuse and pneumonia outcomes, biases inherent to these data should be considered when interpreting results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1513\/annalsats.202206-532oc","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T17:17:15Z","timestamp":1674494235000},"page":"556-565","update-policy":"https:\/\/doi.org\/10.1164\/crossmarkpolicies","source":"Crossref","is-referenced-by-count":7,"title":["Association between Substance Misuse and Outcomes in Critically III Patients with Pneumonia"],"prefix":"10.1093","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7159-0517","authenticated-orcid":false,"given":"Paul M.","family":"Reynolds","sequence":"first","affiliation":[{"name":"University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences"},{"name":"Colorado Pulmonary Outcomes Research Group"},{"name":"Department of Pharmacy, Rocky Mountain Regional VA Medical Center, Aurora, Colorado; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6368-4652","authenticated-orcid":false,"given":"Majid","family":"Afshar","sequence":"additional","affiliation":[{"name":"Division of Pulmonary and Critical Care Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9617-2792","authenticated-orcid":false,"given":"Garth C.","family":"Wright","sequence":"additional","affiliation":[{"name":"University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7775-6266","authenticated-orcid":false,"given":"P. Michael","family":"Ho","sequence":"additional","affiliation":[{"name":"Colorado Pulmonary Outcomes Research Group"},{"name":"Division of Cardiology, Department of Medicine, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7415-3999","authenticated-orcid":false,"given":"Tyree H.","family":"Kiser","sequence":"additional","affiliation":[{"name":"University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences"},{"name":"Colorado Pulmonary Outcomes Research Group"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter D.","family":"Sottile","sequence":"additional","affiliation":[{"name":"Colorado Pulmonary Outcomes Research Group"},{"name":"Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3638-7011","authenticated-orcid":false,"given":"Meghan D.","family":"Althoff","sequence":"additional","affiliation":[{"name":"Colorado Pulmonary Outcomes Research Group"},{"name":"Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Moss","sequence":"additional","affiliation":[{"name":"Colorado Pulmonary Outcomes Research Group"},{"name":"Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4616-7792","authenticated-orcid":false,"given":"Sarah E.","family":"Jolley","sequence":"additional","affiliation":[{"name":"Colorado Pulmonary Outcomes Research Group"},{"name":"Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. William","family":"Vandivier","sequence":"additional","affiliation":[{"name":"Colorado Pulmonary Outcomes Research Group"},{"name":"Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9945-0284","authenticated-orcid":false,"given":"Ellen L.","family":"Burnham","sequence":"additional","affiliation":[{"name":"Colorado Pulmonary Outcomes Research Group"},{"name":"Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,4,1]]},"reference":[{"key":"2026012203263542200_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.chest.2019.08.2180","article-title":"Burden of substance abuse-related admissions to the medical ICU","volume":"157","author":"Westerhausen","year":"2020","journal-title":"Chest"},{"key":"2026012203263542200_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1378\/chest.103.1.21","article-title":"Substance abuse-related admissions to adult intensive care","volume":"103","author":"Baldwin","year":"1993","journal-title":"Chest"},{"key":"2026012203263542200_bib3","doi-asserted-by":"crossref","first-page":"e0250320","DOI":"10.1371\/journal.pone.0250320","article-title":"Association of prescription opioid use on mortality and hospital length of stay in the intensive care unit","volume":"16","author":"Hardy","year":"2021","journal-title":"PLoS One"},{"key":"2026012203263542200_bib4","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1016\/j.bja.2019.03.032","article-title":"Preadmission chronic opioid usage and its association with 90-day mortality in critically ill patients: a retrospective cohort study","volume":"122","author":"Oh","year":"2019","journal-title":"Br J Anaesth"},{"key":"2026012203263542200_bib5","doi-asserted-by":"crossref","first-page":"e0190362","DOI":"10.1371\/journal.pone.0190362","article-title":"Prescription opioids are associated with higher mortality in patients diagnosed with sepsis: a retrospective cohort study using electronic health records","volume":"13","author":"Zhang","year":"2018","journal-title":"PLoS One"},{"key":"2026012203263542200_bib6","first-page":"113","article-title":"Use of opioids and outcomes of pneumonia: results from the US nationwide inpatient sample","volume":"11","author":"Park","year":"2021","journal-title":"J Acute Med"},{"key":"2026012203263542200_bib7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fnins.2020.00569","article-title":"One is not enough: understanding and modeling polysubstance use","volume":"14","author":"Crummy","year":"2020","journal-title":"Front Neurosci"},{"key":"2026012203263542200_bib8","doi-asserted-by":"crossref","first-page":"e195172","DOI":"10.1001\/jamanetworkopen.2019.5172","article-title":"Association between alcohol use disorders and outcomes of patients hospitalized with community-acquired pneumonia","volume":"2","author":"Gupta","year":"2019","journal-title":"JAMA Netw Open"},{"key":"2026012203263542200_bib9","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1164\/rccm.201910-2021OC","article-title":"Noninvasive ventilation use in critically ill patients with acute asthma exacerbations","volume":"202","author":"Althoff","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203263542200_bib10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/ajad.12898","article-title":"Cannabis use disorder and epilepsy: a cross-national analysis of 657\u2009072 hospitalized patients","volume":"28","author":"Patel","year":"2019","journal-title":"Am J Addict"},{"key":"2026012203263542200_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jns.2016.01.066","article-title":"Recreational marijuana use and acute ischemic stroke: a population-based analysis of hospitalized patients in the United States","volume":"364","author":"Rumalla","year":"2016","journal-title":"J Neurol Sci"},{"key":"2026012203263542200_bib12","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1097\/CCM.0000000000003288","article-title":"Half-dose versus full-dose alteplase for treatment of pulmonary embolism","volume":"46","author":"Kiser","year":"2018","journal-title":"Crit Care Med"},{"key":"2026012203263542200_bib13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.201706-1132OC","article-title":"An observational study of the efficacy of cisatracurium compared with vecuronium in patients with or at risk for acute respiratory distress syndrome","volume":"197","author":"Sottile","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203263542200_bib14","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/phar.2212","article-title":"Evaluation of prophylactic heparin dosage strategies and risk factors for venous thromboembolism in the critically ill patient","volume":"39","author":"Reynolds","year":"2019","journal-title":"Pharmacotherapy"},{"key":"2026012203263542200_bib15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/MLR.0000000000000905","article-title":"Validation of the combined comorbidity index of Charlson and Elixhauser to predict 30-day mortality across ICD-9 and ICD-10","volume":"56","author":"Simard","year":"2018","journal-title":"Med Care"},{"key":"2026012203263542200_bib16","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia: an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203263542200_bib17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1164\/rccm.2102084","article-title":"Severe community-acquired pneumonia: use of intensive care services and evaluation of American and British Thoracic Society Diagnostic criteria","volume":"166","author":"Angus","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012203263542200_bib18","doi-asserted-by":"crossref","first-page":"e210242","DOI":"10.1001\/jamanetworkopen.2021.0242","article-title":"Assessment of annual cost of substance use disorder in US hospitals","volume":"4","author":"Peterson","year":"2021","journal-title":"JAMA Netw Open"},{"key":"2026012203263542200_bib19","doi-asserted-by":"crossref","first-page":"109383","DOI":"10.1016\/j.drugalcdep.2022.109383","article-title":"Substance use disorders and COVID-19: an analysis of nation-wide Veterans Health Administration electronic health records","volume":"234","author":"Hasin","year":"2022","journal-title":"Drug Alcohol Depend"},{"key":"2026012203263542200_bib20","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/phar.2602","article-title":"The immunomodulatory effects of opioids and implications for intensive care unit populations","volume":"41","author":"Mefford","year":"2021","journal-title":"Pharmacotherapy"},{"key":"2026012203263542200_bib21","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1007\/s11606-020-06155-9","article-title":"The association between prescribed opioid receipt and community-acquired pneumonia in adults: a systematic review and meta-analysis","volume":"35","author":"Steffens","year":"2020","journal-title":"J Gen Intern Med"},{"key":"2026012203263542200_bib22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.7326\/M17-1907","article-title":"Opioid analgesic use and risk for invasive pneumococcal diseases: a nested case-control study","volume":"168","author":"Wiese","year":"2018","journal-title":"Ann Intern Med"},{"key":"2026012203263542200_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/QAI.0000000000002310","article-title":"Trajectories of self-reported opioid use among patients with HIV engaged in care: results from a national cohort study","volume":"84","author":"Edelman","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026012203263542200_bib24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1080\/08897077.2019.1576088","article-title":"Substance use is independently associated with pneumonia severity in persons living with the human immunodeficiency virus (HIV)","volume":"40","author":"Jolley","year":"2019","journal-title":"Subst Abus"},{"key":"2026012203263542200_bib25","doi-asserted-by":"crossref","first-page":"829715","DOI":"10.3389\/fpubh.2022.829715","article-title":"Cannabis use is associated with lower COVID-19 susceptibility but poorer survival","volume":"10","author":"Huang","year":"2022","journal-title":"Front Public Health"},{"key":"2026012203263542200_bib26","doi-asserted-by":"crossref","first-page":"107557","DOI":"10.1016\/j.drugalcdep.2019.107557","article-title":"Regular cannabis use, with and without tobacco co-use, is associated with respiratory disease","volume":"204","author":"Winhusen","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"2026012203263542200_bib27","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1007\/s11606-022-07424-5","article-title":"Rethinking the use of \u201cpolysubstance\u201d to describe complex substance use patterns","volume":"37","author":"Shearer","year":"2022","journal-title":"J Gen Intern Med"},{"key":"2026012203263542200_bib28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41380-020-00949-3","article-title":"Polysubstance use in the U.S. opioid crisis","volume":"26","author":"Compton","year":"2021","journal-title":"Mol Psychiatry"},{"key":"2026012203263542200_bib29","doi-asserted-by":"crossref","first-page":"e0255514","DOI":"10.1371\/journal.pone.0255514","article-title":"Brief report: cannabis and opioid use disorder among heart failure admissions, 2008-2018","volume":"16","author":"Chouairi","year":"2021","journal-title":"PLoS One"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/20\/4\/556\/66270296\/annalsats_20_4_556.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/20\/4\/556\/66270296\/annalsats_20_4_556.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T08:27:28Z","timestamp":1769070448000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/20\/4\/556\/8414877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":29,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4,1]]},"published-print":{"date-parts":[[2023,4,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.202206-532oc","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4]]},"published":{"date-parts":[[2023,4,1]]},"assertion":[{"value":"2022-06-20","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-01-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}